Gillings-backed fund acquires U.K. pharma development company

GHO Capital, a London-based investment fund with backing from Quintiles (NYSE: Q) founder Dennis Gillings, acquired Quotient Clinical, which provides outsourced, early-stage drug development services to the pharmaceutical industry. Based in the United Kingdom, Quotient employs 280 and helps “pharmaceutical and biotechnology customers to improve research and development productivity and accelerate drug development timelines.” Though much smaller, Quotient is not unlike Quintiles, which Gillings…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news